Full Text (PDF)
Letter to Editor

Behcets Disease in an Immunocompromised Female

Pragya A. Nair, Priya Ghoghara, Kishan Jadav, Mauli Shah

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


RFP Journal of Dermatology 10(1):p 29-31, jan-june 2025. | DOI: 10.21088/jd.2582.3582 10125.5

How Cite This Article:

Ghoghara P, Jadav K, Shah M, Nair PA. Behcets disease in an immunocompromised female. RFP J Dermatol. 2025;10(1):29-31.

Timeline

Received : May 29, 2025         Accepted : June 15, 2025          Published : June 30, 2025

Abstract

A 49 year old female presented to theoutpatient department of dermatology withraw areas in oral cavity and genitals. She had multiple reddish elevated lesions withpain and burning sensation all over body.Patient had complaints of watering from eyes, headache, fever,weight loss, left knee joint pain and burning micturition. Past history
of three similar episode was present. Nohistory of blood transfusion, IV drug abuse,tattooing, any sexual transmitted diseaseorany signicant family could be elicited. Noassociated comorbidities were elicited.Cutaneous examination revealed few shallow (6-8) erosions with an erythematous halo over tongue and left side of soft palate.
Figure1a Few deep erosions present over labiamajora, labia minora and vaginal mucosa.Figure 1b Multiple grouped vesicles, papulesand pustules present over nape of neck, chest,bilateral axilla, abdomen, back and rightleg. There were longitudinal ridges presentover nails of right foot. Ophthalmologic alexamination showed few erosions over left (3.4 mg/dl), and albumin to globulin ratio(0.89) was decreased. Rest of the investigations includingC reactive protein, electrolytes, liverfunction test, histogram, differential count,urea, creatinine and G6PD were normal. As per the clinical features, blood reports andhistopathological examination, patient waslabelled as case of Bechet’s diseasein HIV patient.


References

  • 1.   Singal A., Chhabra N., Pandhi D., Rohatgi J. Behçet’s disease in India: a dermatological perspective. Indian J Dermatol Venereol Leprol. 2013; 79(2): 199-204.
  • 2.   Gomez-Puerta J.A., Espinosa G., Miro J.M., Sued O., Llibre J.M., Cervera R., et al. Behcet’s disease in an HIV-1-infected patient treated with highly active antiretroviral therapy. Isr Med Assoc J 2006; 8: 513–4.
  • 3.   Marih L., Sodqi M., Marhoum El Filali K., Chakib A. Behcet’s disease revealed by deep vein thrombosis in an HIV-1-infected patient. J Mal Vasc 2012; 37: 320–2.
  • 4.   Mahajan V.K., Sharma N.L., Sharma V.C., Sharma R.C., Sarin S. Behcet’s disease with HIV infection: response to antiretroviral therapy. Indian J Dermatol Venereol Leprol 2005; 71: 276–8.
  • 5.   A NP, Juhi S., Jinal T., Dharmesh P. Diagnostic criteria in dermatology. Indian J Dermatol Venereol Leprol 2023; 89: 771-9
  • 6.   Kharkar V., Yeole S., Mahajan S., Gutte R., Khopkar U., Sujatha M.R. Behcet’s disease simulating secondary syphilis in an HIVinfected patient. Indian J Sex Transm Dis AIDS. 2013 ; 34(1): 62-4.
  • 7.   Cicalini S., Gigli B., Palmieri F., Boumis E., Froio N., Petrosillo N. Remission of Behcet’s disease and keratoconjunctivitis sicca in an HIV-infected patient treated with HAART. Int J STD AIDS 2004; 15: 139140.

Data Sharing Statement

There are no additional data available

Funding

This research received no funding

Author Contributions

All authors contributed significantly to the work and approve its publication

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval

Acknowledgements

Information Not Provided

Conflicts of Interest

No conflicts of interest in this work


About this article


Cite this article

Ghoghara P, Jadav K, Shah M, Nair PA. Behcets disease in an immunocompromised female. RFP J Dermatol. 2025;10(1):29-31.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Received Accepted Published
May 29, 2025 June 15, 2025 June 30, 2025

DOI: 10.21088/jd.2582.3582 10125.5

Keywords

BD is believed to be due to an autoimmune process triggered by an infectious or environmental agent in genetically predisposed individuals

Article Level Metrics

Last Updated

Monday 26 January 2026, 18:55:47 (IST)


35

Accesses

0
4
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received May 29, 2025
Accepted June 15, 2025
Published June 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Access this article



Share